DelMar Pharmaceuticals Inc Share Price OTC Bulletin Board
Equities
DMPI
US2470781087
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
14/05 | Kintara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
03/04 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.82M 569M |
---|---|---|---|---|---|
Net income 2022 | -22M -1.84B | Net income 2023 | -14M -1.17B | EV / Sales 2022 | - |
Net cash position 2022 | 11.78M 983M | Net cash position 2023 | 2.61M 218M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.54
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.87% |
Latest transcript on DelMar Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 11/18/11 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 11/18/11 |
Tamara Favorito
BRD | Director/Board Member | 65 | 29/21/29 |
Laura Douglass
BRD | Director/Board Member | 59 | 26/20/26 |
1st Jan change | Capi. | |
---|---|---|
+18.62% | 125B | |
+15.54% | 109B | |
-1.80% | 24.74B | |
+2.97% | 22.67B | |
-9.86% | 18.14B | |
-41.04% | 16.67B | |
-12.25% | 16.64B | |
+0.20% | 13.45B | |
+22.81% | 11.32B |
- Stock Market
- Equities
- KTRA Stock
- DMPI Stock